These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
471 related articles for article (PubMed ID: 10880254)
1. Presence of interleukin 10 in the serum and blister fluid of patients with pemphigus vulgaris and pemphigoid. Bhol KC; Rojas AI; Khan IU; Ahmed AR Cytokine; 2000 Jul; 12(7):1076-83. PubMed ID: 10880254 [TBL] [Abstract][Full Text] [Related]
2. Bullous pemphigoid: interaction of interleukin 5, anti-basement membrane zone antibodies and eosinophils. A preliminary observation. Engineer L; Bhol K; Kumari S; Razzaque Ahmed A Cytokine; 2001 Jan; 13(1):32-38. PubMed ID: 11145840 [TBL] [Abstract][Full Text] [Related]
3. Mediators of inflammation in blister fluids from patients with pemphigus vulgaris and bullous pemphigoid. Grando SA; Glukhenky BT; Drannik GN; Epshtein EV; Kostromin AP; Korostash TA Arch Dermatol; 1989 Jul; 125(7):925-30. PubMed ID: 2662908 [TBL] [Abstract][Full Text] [Related]
4. Increased expression of eotaxin and its specific receptor CCR3 in bullous pemphigoid. Frezzolini A; Teofoli P; Cianchini G; Barduagni S; Ruffelli M; Ferranti G; Puddu P; De Pita O Eur J Dermatol; 2002; 12(1):27-31. PubMed ID: 11809592 [TBL] [Abstract][Full Text] [Related]
6. Serum levels of BAFF are increased in bullous pemphigoid but not in pemphigus vulgaris. Asashima N; Fujimoto M; Watanabe R; Nakashima H; Yazawa N; Okochi H; Tamaki K Br J Dermatol; 2006 Aug; 155(2):330-6. PubMed ID: 16882171 [TBL] [Abstract][Full Text] [Related]
7. Pemphigus vulgaris: the role of IL-1 and IL-1 receptor antagonist in pathogenesis and effects of intravenous immunoglobulin on their production. Bhol KC; Desai A; Kumari S; Colon JE; Ahmed AR Clin Immunol; 2001 Aug; 100(2):172-80. PubMed ID: 11465946 [TBL] [Abstract][Full Text] [Related]
8. Biology of interleukin-5 in ocular cicatricial pemphigoid. Letko E; Bhol K; Colon J; Foster CS; Ahmed AR Graefes Arch Clin Exp Ophthalmol; 2002 Jul; 240(7):565-9. PubMed ID: 12136288 [TBL] [Abstract][Full Text] [Related]
9. Interleukin 1 components in cicatricial pemphigoid. Role in intravenous immunoglobulin therapy. Kumari S; Bhol KC; Rehman F; Foster CS; Ahmed AR Cytokine; 2001 May; 14(4):218-24. PubMed ID: 11448121 [TBL] [Abstract][Full Text] [Related]
10. In vitro organ culture model for mucous membrane pemphigoid. Colón JE; Bhol KC; Razzaque MS; Ahmed AR Clin Immunol; 2001 Feb; 98(2):229-34. PubMed ID: 11161979 [TBL] [Abstract][Full Text] [Related]
11. Increased serum levels of circulating CD40 ligand in patients with bullous pemphigoid: preliminary results. Watanabe R; Ishiura N; Nakashima H; Yazawa N; Kuwano Y; Tada Y; Okochi H; Fujimoto M; Tamaki K Dermatology; 2007; 215(3):180-6. PubMed ID: 17823512 [TBL] [Abstract][Full Text] [Related]
12. Increased serum IL-6, TNF-alpha and IL-10 levels in patients with bullous pemphigoid: relationships with disease activity. D'Auria L; Mussi A; Bonifati C; Mastroianni A; Giacalone B; Ameglio F J Eur Acad Dermatol Venereol; 1999 Jan; 12(1):11-5. PubMed ID: 10188143 [TBL] [Abstract][Full Text] [Related]
13. Role of BP180NC16a-enzyme-linked immunosorbent assay (ELISA) in the diagnosis of bullous pemphigoid in China. Feng S; Lin L; Jin P; Wu Q; Zhou W; Sang H; Shao C Int J Dermatol; 2008 Jan; 47(1):24-8. PubMed ID: 18173596 [TBL] [Abstract][Full Text] [Related]
14. Lesional Th17 cells and regulatory T cells in bullous pemphigoid. Arakawa M; Dainichi T; Ishii N; Hamada T; Karashima T; Nakama T; Yasumoto S; Tsuruta D; Hashimoto T Exp Dermatol; 2011 Dec; 20(12):1022-4. PubMed ID: 22017210 [TBL] [Abstract][Full Text] [Related]
16. Increased serum levels of a proliferation-inducing ligand in patients with bullous pemphigoid. Watanabe R; Fujimoto M; Yazawa N; Nakashima H; Asashima N; Kuwano Y; Tada Y; Maruyama N; Okochi H; Tamaki K J Dermatol Sci; 2007 Apr; 46(1):53-60. PubMed ID: 17250993 [TBL] [Abstract][Full Text] [Related]
17. CCL18 is expressed in patients with bullous pemphigoid and parallels disease course. Günther C; Carballido-Perrig N; Kopp T; Carballido JM; Pfeiffer C Br J Dermatol; 2009 Apr; 160(4):747-55. PubMed ID: 19120345 [TBL] [Abstract][Full Text] [Related]
18. The role of antibody to human beta4 integrin in conjunctival basement membrane separation: possible in vitro model for ocular cicatricial pemphigoid. Chan RY; Bhol K; Tesavibul N; Letko E; Simmons RK; Foster CS; Ahmed AR Invest Ophthalmol Vis Sci; 1999 Sep; 40(10):2283-90. PubMed ID: 10476794 [TBL] [Abstract][Full Text] [Related]
19. Cytokine pattern in blister fluid and sera of patients with pemphigus. Baroni A; Perfetto B; Ruocco E; Greco R; Criscuolo D; Ruocco V Dermatology; 2002; 205(2):116-21. PubMed ID: 12218224 [TBL] [Abstract][Full Text] [Related]
20. Cytokines in the sera of patients with pemphigus vulgaris: interleukin-6 and tumour necrosis factor-alpha levels are significantly increased as compared to healthy subjects and correlate with disease activity. D'Auria L; Bonifati C; Mussi A; D'Agosto G; De Simone C; Giacalone B; Ferraro C; Ameglio F Eur Cytokine Netw; 1997 Dec; 8(4):383-7. PubMed ID: 9459618 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]